← Back to Search

Behavioural Intervention

Mobile Health Rehabilitation for Heart Disease (RESILIENT Trial)

N/A
Waitlist Available
Led By John Dodson, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥65
Capable of self-consent
Must not have
Moderate or severe cognitive impairment
Severe osteoarthritis, or joint replacement within last 3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if a mobile health program can help improve heart function in older adults compared to traditional care. A total of 400 patients will be enrolled and followed for at least 3 months.

Who is the study for?
This trial is for older adults aged 65 or above who have been hospitalized for ischemic heart disease (like a heart attack, stent placement, or bypass surgery) recently. They must be able to walk, give consent themselves, and use mobile health technology in English or Spanish. People with severe movement disorders, very short life expectancy, severe cognitive issues, certain recent surgeries or conditions that limit walking are not eligible.
What is being tested?
The RESILIENT study tests if a mobile health cardiac rehab program (mHealth-CR) can improve the physical function of older adults after hospitalization due to heart disease better than standard care. Participants will either receive mHealth-CR or usual care in a ratio of 3:1 by random selection.
What are the potential side effects?
Since this trial involves non-drug interventions like using mobile health technology for rehabilitation exercises at home rather than medication side effects may include discomfort from exercise and potential injury if exercises are performed improperly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am able to understand and agree to the study on my own.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have significant memory or thinking problems.
Select...
I have severe joint pain or had a joint replacement recently.
Select...
I regularly use a walker to move around.
Select...
I cannot use mobile health apps in English or Spanish.
Select...
I have a groin injury from a heart procedure that stops me from walking quickly.
Select...
I have Parkinson's disease or a similar movement disorder.
Select...
I cannot walk by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average weekly percent completion of the mHealth-CR program
Change in 6-minute walking distance (6MWD)
Secondary study objectives
Change in 12-Item Short Form Survey (SF-12) score
Change in Activities of Daily Living (ADLs)
Change in Basic Activities of Daily Living (BADLs)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: mHealth-CRExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,413 Previous Clinical Trials
855,372 Total Patients Enrolled
22 Trials studying Coronary Artery Disease
15,910 Patients Enrolled for Coronary Artery Disease
National Institutes of Health (NIH)NIH
2,823 Previous Clinical Trials
8,162,514 Total Patients Enrolled
10 Trials studying Coronary Artery Disease
11,491 Patients Enrolled for Coronary Artery Disease
John Dodson, MDPrincipal InvestigatorNew York Langone Health
3 Previous Clinical Trials
41 Total Patients Enrolled

Media Library

mHealth-CR (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03978130 — N/A
Coronary Artery Disease Research Study Groups: mHealth-CR, Usual Care
Coronary Artery Disease Clinical Trial 2023: mHealth-CR Highlights & Side Effects. Trial Name: NCT03978130 — N/A
mHealth-CR (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03978130 — N/A
~68 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top